Biomarin Pharmaceutical Inc (BMRN) is a biotechnology company listed on NASDAQ.
Latest reported BMRN revenue for 2026-06-30 was $1.76B. Net income was $150.3M. BMRN currently screens at market cap $10.63B and trailing P/E 39.6.
Use this BMRN page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the BMRN quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the BMRN SEC filings page. Lician reads the product cache first so this HTML stays unique to Biomarin Pharmaceutical Inc even when a live quote feed is slow.
Latest cached year on this hub. Full BMRN income, balance, and cash tables.